However, liver enzyme concentrations alone should not be used as a surrogate marker for NAFLD and NASH since some patients with these diseases have normal AST and ALT concentrations in the circulation [42]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.